Krosyl Pharmaceuticals Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Krosyl Pharmaceuticals Private Limited Pharmaceutical Export Portfolio Dataset — 4 Products, $600.0K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Krosyl Pharmaceuticals Private Limited — Pharmaceutical Exporter Profile (2026) | 4 Products, $600.0K Trade | TransData Nexus

Who is Krosyl Pharmaceuticals Private Limited? — Company Overview & Market Position

Krosyl Pharmaceuticals Private Limited, established on January 5, 2015, is a privately held pharmaceutical company headquartered in Vadodara, Gujarat, India. The company is registered under the Corporate Identification Number (CIN) U24100GJ2015PTC081717. With an authorized and paid-up capital of ₹5 million, Krosyl Pharmaceuticals operates in the manufacturing sector, focusing on the production of pharmaceutical finished formulations.

The company's mission is to become a global healthcare organization recognized for its integrated healthcare and pharmaceutical solutions through innovation, quality, and competence. Krosyl Pharmaceuticals aims to provide high-quality, affordable medicines to support patients in need, striving to improve access and affordability, create healthier communities, and promote a healthy mind, body, and environment worldwide.

What Does Krosyl Pharmaceuticals Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Albendazole$150.0K 2Flucloxacillin$150.0K 3Fluconazole$150.0K 4Mebendazole$150.0K

Krosyl Pharmaceuticals Private Limited Therapeutic Categories — 3 Specializations

Krosyl Pharmaceuticals Private Limited operates across 3 therapeutic categories, with Antimalarial & Antiparasitic (50.0%), Advanced Antibiotics (25.0%), Antifungals (25.0%) representing the largest segments by export value. The portfolio is concentrated — the top 5 products account for 100% of total exports.

Antimalarial & Antiparasitic

2 products · 50.0% · $300.0K

Advanced Antibiotics

1 products · 25.0% · $150.0K

Antifungals

1 products · 25.0% · $150.0K

Product Portfolio — Top 4 by Export Value

Krosyl Pharmaceuticals Private Limited exports 4 pharmaceutical products across 3 therapeutic categories. Market leader (#1 exporter) in 1 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Albendazole	Antimalarial & Antiparasitic	$150.0K	3	0.2%	9
2	Flucloxacillin

Key Metrics

Total Trade$600.0K

Products4

Shipments12

Categories3

#1 Rankings1

Top 5 Concentration100.0%

Top Categories

Antimalarial & Antiparasitic50.0%

Advanced Antibiotics25.0%

Antifungals25.0%

Last updated: March 28, 2026

Krosyl Pharmaceuticals Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Krosyl Pharmaceuticals operates manufacturing facilities in Vadodara, Gujarat, India. The company emphasizes maintaining high-quality standards in its manufacturing processes, adhering to Good Manufacturing Practice (GMP) guidelines. Krosyl Pharmaceuticals is certified by the World Health Organization (WHO) for GMP compliance, ISO 9001:2008, and Good Laboratory Practice (GLP), ensuring the production of safe and effective pharmaceutical products.

Buyer Due Diligence Brief — Evaluating Krosyl Pharmaceuticals Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Krosyl Pharmaceuticals maintains a strong track record in pharmaceutical manufacturing, as evidenced by its WHO-GMP and ISO 9001:2008 certifications. The company's commitment to quality and compliance with international standards indicates reliability in its manufacturing processes. While specific export volumes and consistency data are not publicly available, the company's certifications suggest a focus on delivering high-quality products to its customers.

2Certifications to Verify

Importers should verify the following certifications when considering Krosyl Pharmaceuticals as a supplier:

WHO-GMP Certification: Indicates compliance with international manufacturing standards. Verification can be done through the World Health Organization's official channels.

ISO 9001:2008 Certification: Demonstrates adherence to quality management systems. Verification can be conducted through the International Organization for Standardization's official website.

3Due Diligence Checklist

When conducting due diligence on Krosyl Pharmaceuticals, consider the following steps:

Verify Certifications: Confirm the validity of WHO-GMP and ISO 9001:2008 certifications through official channels.

Assess Financial Health: Review the company's financial statements for the latest fiscal year to evaluate profitability and financial stability.

Evaluate Regulatory Compliance: Ensure the company adheres to relevant regulatory standards in target markets.

Review Product Portfolio: Examine the range and quality of products offered to ensure they meet your requirements.

Check References: Seek feedback from existing clients or partners to gauge reliability and service quality.

By following this checklist, importers can make informed decisions regarding potential partnerships with Krosyl Pharmaceuticals.

TransData Nexus Research · FDA, WHO, EMA regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Supplier Matching: Krosyl Pharmaceuticals Private Limited identified across shipments using name normalization.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
3.Market Share: Calculated per product as Krosyl Pharmaceuticals Private Limited's capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 12 individual customs records matching Krosyl Pharmaceuticals Private Limited.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

4 Products Tracked

3 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

Krosyl Pharmaceuticals Private Limited

Krosyl Pharmaceuticals Private Limited — Export Portfolio & Destination Treemap

Who is Krosyl Pharmaceuticals Private Limited? — Company Overview & Market Position

What Does Krosyl Pharmaceuticals Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

Krosyl Pharmaceuticals Private Limited Therapeutic Categories — 3 Specializations

Product Portfolio — Top 4 by Export Value

Key Metrics

Top Categories

Krosyl Pharmaceuticals Private Limited — Corporate Profile & Information

1Corporate Overview

2Manufacturing Facilities

Top Export Routes

Related Analysis

Need Detailed Data?

3Key Leadership

Where Does Krosyl Pharmaceuticals Private Limited Export? — Destination Intelligence

1Regulated Markets

2Emerging Markets

3Geographic Strategy

Krosyl Pharmaceuticals Private Limited — Manufacturing & Regulatory Profile

1FDA Status

2WHO & EU GMP

3CDSCO & Indian Regulatory

4Recent Regulatory Actions

Krosyl Pharmaceuticals Private Limited — Competitive Positioning Among Indian Pharma Exporters

1Competitive Landscape

2Key Differentiators

3Strategic Position

Buyer Due Diligence Brief — Evaluating Krosyl Pharmaceuticals Private Limited as a Supplier

1Supplier Assessment

2Certifications to Verify

3Due Diligence Checklist

Frequently Asked Questions — Krosyl Pharmaceuticals Private Limited

How many pharmaceutical products does Krosyl Pharmaceuticals Private Limited export from India?

What is Krosyl Pharmaceuticals Private Limited's total pharmaceutical export value?

In which products is Krosyl Pharmaceuticals Private Limited the #1 Indian exporter?

What therapeutic categories does Krosyl Pharmaceuticals Private Limited cover?

Get Full Krosyl Pharmaceuticals Private Limited Export Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology